Minos Biosciences

Minos Biosciences is a Paris-based deeptech startup spun out of ESPCI Paris-PSL, developing a breakthrough platform for high-throughput single-cell analysis. The company's technology combines state-of-the-art microfluidics, molecular biology, image analysis, and bioinformatics to directly couple phenotypic data (microscopy) with multi-omic data (DNA/RNA sequencing) at single-cell resolution across tens of thousands of cells simultaneously. Founded in January 2020 by researchers Hubert Geisler and Gael Blivet-Bailly, Minos targets the life sciences research and clinical diagnostics markets, with applications in oncology and personalized medicine. The company raised a 1.5M EUR seed round in 2021 led by Elaia through the PSL Innovation Fund.